Mounjaro is the brand name for Tirzepatide, a drug used to treat Type 2 diabetes. In 2023, the United States Food and Drug Administration (FDA) approved it for weight loss. The caption ended as ...

To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...

Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide (Mounjaro) rather than increasing the dose of the earlier-generation GLP-1 ...

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

After Hims & Hers (HIMS) announced yesterday that the company is broadening its weight loss offering to include Lilly’s (LLY) branded ...

Primary endpoint met in the 8-week treatment study (highly statistically significant). Co-administered group had a 4.4% reduction in weight compared to 1.6% for the placebo group (p<0.0001).

Tirzepatide — the main active ingredient in brand name Mounjaro — is also prescribed under the brand name Zepbound, which is FDA approved for weight loss specifically for qualifying individuals.

Meghan Trainor knows she made you look. The “All About That Bass” singer addressed her recent weight loss transformation in a post on social media, citing several ways she changed her body ...

or by people sending in photos of themselves. Instead, they will have to verify the person's body mass index (BMI) via a video consultation, in person, or through accessing GP or medical records. If ...